Zheng Quan Zhi Xing·2025-08-05 16:20Core Viewpoint - The company has decided to extend the authorization period for using temporarily idle raised funds for cash management, ensuring that it does not affect the normal operation of fundraising investment projects and the safety of the raised funds [3][4][7]. Group 1: Fundraising Overview - The company issued 7,000,000 convertible bonds with a total fundraising amount of RMB 700 million, netting RMB 688.27 million after deducting related fees [1]. - The funds are stored in a dedicated account, and a regulatory agreement has been established with relevant parties to ensure proper management [2]. Group 2: Investment Project Details - The total investment for the fundraising projects is RMB 72 million, with RMB 68.83 million allocated from the raised funds for the following projects: - 康泰产业园建设项目 (Kangtai Industrial Park Construction Project): Total investment of RMB 490 million, with RMB 478.27 million from raised funds - 康泰医学医疗器械产业园项目 (Kangtai Medical Device Industrial Park Project): Total investment of RMB 230 million, with RMB 210 million from raised funds [2]. Group 3: Cash Management Authorization - The company approved the use of up to RMB 650 million of temporarily idle funds for cash management, with the authorization period extended for another 12 months, from August 6, 2025, to August 5, 2026 [3][4][5]. - The funds can be rolled over within the authorized limits and must be returned to the dedicated account upon maturity [5][7]. Group 4: Risk Management and Compliance - The company will select cash management products that are high in safety and liquidity, ensuring compliance with relevant regulations and avoiding high-risk investments [5][6]. - The board has confirmed that the extension of cash management authorization will not affect the normal operation of fundraising projects or the company's main business [6][7][8].